1. RESEARCH SCOPE
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP-DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION
3. EXECUTIVE SUMMARY
3.1. MARKET SUMMARY
3.2. KEY FINDINGS
3.2.1. NORTH AMERICA GENERATES OVER 40% OF THE GLOBAL REVENUE
3.2.2. LARGE SCALE INVESTMENT IN THE ARTIFICIAL INTELLIGENCE MARKET
3.2.3. DEEP LEARNING EXHIBITING A HUGE DEMAND IN THE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET
4. MARKET DYNAMICS
4.1. ETYMOLOGY OF ARTIFICIAL INTELLIGENCE IN HEALTHCARE
4.2. MARKET DEFINITION AND SCOPE
4.3. INDUSTRY COMPONENTS
4.3.1. ARTIFICIAL INTELLIGENCE ANALYSIS
4.3.2. DATA WAREHOUSE
4.3.3. SOFTWARE DEVELOPMENT
4.4. LEGAL, POLICY AND REGULATORY ISSUES
4.5. MARKET DRIVERS
4.5.1. RISE IN BIG DATA IN HEALTHCARE INDUSTRY
4.5.2. EMERGENCE OF PERSONALIZED MEDICINE IN TESTS FOR CLINICAL DECISION MAKING
4.5.3. INCREASING ADOPTION OF ARTIFICIAL INTELLIGENCE (AI) IN GENETICS
4.5.4. AI CREATING A REAL-TIME MONITORING SYSTEM
4.5.5. HEALTHCARE WEARABLES PLAYING AN IMPORTANT ROLE IN MONITORING
4.6. MARKET RESTRAINTS
4.6.1. SLOW ADOPTION OF AI BASED TECHNOLOGIES
4.6.2. AMBIGUOUS REGULATORY GUIDELINES FOR MEDICAL SOFTWARE
4.7. MARKET OPPORTUNITIES
4.7.1. HEALTHCARE WORKER TO PATIENT RATIO BEING BALANCED WITH AI
4.7.2. USE OF AI IN INNOVATIVE SURGERIES
4.7.3. INTEGRATION WITH EXISTING SYSTEMS
4.8. MARKET CHALLENGES
4.8.1. LACK OF USABLE DATA IN HEALTHCARE
4.8.2. CHALLENGE TO MAINTAIN DATA SECURITY
5. MARKET BY OFFERING
5.1. HARDWARE
5.2. SOFTWARE
5.3. SERVICES
6. MARKET BY TECHNOLOGY
6.1. CONTEXT AWARE PROCESSING
6.2. DEEP LEARNING
6.3. NATURAL LANGUAGE PROCESSING
6.4. QUERYING METHOD
7. MARKET BY APPLICATION
7.1. DRUG DISCOVERY
7.2. INPATIENT CARE & HOSPITAL MANAGEMENT
7.3. LIFESTYLE MANAGEMENT & MONITORING
7.4. MEDICAL IMAGING & DIAGNOSTICS
7.5. PATIENT DATA & RISK ANALYSIS
7.6. PRECISION MEDICINE
7.7. RESEARCH
7.8. VIRTUAL ASSISTANT
7.9. WEARABLES
8. MARKET BY END USERS
8.1. ACOS & MCOS
8.2. PATIENTS
8.3. PAYERS
8.4. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
8.5. PROVIDERS
9. KEY ANALYTICS
9.1. PORTER”S FIVE FORCE ANALYSIS
9.1.1. THREAT OF NEW ENTRANTS
9.1.2. THREAT OF SUBSTITUTE
9.1.3. BARGAINING POWER OF SUPPLIERS
9.1.4. BARGAINING POWER OF BUYERS
9.1.5. INTENSITY OF COMPETITIVE RIVALRY
9.2. OPPORTUNITY MATRIX
9.3. KEY BUYING CRITERIA
9.3.1. APPLICATION
9.3.2. TECHNOLOGY
9.3.3. INTEGRATION WITH EXISTING INFRASTRUCTURE
9.4. INVESTMENT ANALYSIS
9.4.1. FASTEST GROWING REVENUE SEGMENT-WISE OPPORTUNITIES
10. GEOGRAPHICAL ANALYSIS
10.1. UNITED STATES
10.2. CANADA
11. COMPETITIVE LANDSCAPE
11.1. MARKET SHARE ANALYSIS
11.2. TOP 5 COMPANIES
11.2.1. GOOGLE INC
11.2.2. INTERNATIONAL BUSINESS MACHINES (IBM) CORPORATION
11.2.3. INTEL CORPORATION
11.2.4. MICROSOFT CORPORATION
11.2.5. GE HEALTHCARE
11.3. KEY STRATEGIES
11.3.1. PRODUCT LAUNCH
11.3.2. PARTNERSHIP & COLLABORATION
11.3.3. MERGER & ACQUISITION
11.3.4. INVESTMENTS
11.3.5. EXPANSIONS
11.4. COMPANY PROFILES
11.4.1. DEEP GENOMICS INC.
11.4.1.1. OVERVIEW
11.4.1.2. PRODUCT PORTFOLIO
11.4.1.3. STRATEGIC INITIATIVES
11.4.1.4. SCOT ANALYSIS
11.4.2. ENLITIC INC.
11.4.2.1. OVERVIEW
11.4.2.2. PRODUCT PORTFOLIO
11.4.2.3. STRATEGIC INITIATIVES
11.4.2.4. SCOT ANALYSIS
11.4.3. GE HEALTHCARE
11.4.3.1. OVERVIEW
11.4.3.2. PRODUCT PORTFOLIO
11.4.3.3. STRATEGIC INITIATIVES
11.4.3.4. SCOT ANALYSIS
11.4.4. GENERAL VISION INC
11.4.4.1. OVERVIEW
11.4.4.2. PRODUCT PORTFOLIO
11.4.4.3. STRATEGIC INITIATIVES
11.4.4.4. SCOT ANALYSIS
11.4.5. GOOGLE INC
11.4.5.1. OVERVIEW
11.4.5.2. PRODUCT PORTFOLIO
11.4.5.3. STRATEGIC INITIATIVES
11.4.5.4. SCOT ANALYSIS
11.4.6. INTERNATIONAL BUSINESS MACHINES CORPORATION (IBM)
11.4.6.1. OVERVIEW
11.4.6.2. PRODUCT PORTFOLIO
11.4.6.3. STRATEGIC INITIATIVES
11.4.6.4. SCOT ANALYSIS
11.4.7. ICARBONX
11.4.7.1. OVERVIEW
11.4.7.2. PRODUCT PORTFOLIO
11.4.7.3. STRATEGIC INITIATIVES
11.4.7.4. SCOT ANALYSIS
11.4.8. INTEL CORPORATION
11.4.8.1. OVERVIEW
11.4.8.2. PRODUCT PORTFOLIO
11.4.8.3. STRATEGIC INITIATIVES
11.4.8.4. SCOT ANALYSIS
11.4.9. MICROSOFT CORPORATION
11.4.9.1. OVERVIEW
11.4.9.2. PRODUCT PORTFOLIO
11.4.9.3. STRATEGIC INITIATIVES
11.4.9.4. SCOT ANALYSIS
11.4.10. NEXT IT CORPORATION
11.4.10.1. OVERVIEW
11.4.10.2. PRODUCT PORTFOLIO
11.4.10.3. STRATEGIC INITIATIVES
11.4.10.4. SCOT ANALYSIS
11.4.11. NVIDIA CORPORATION
11.4.11.1. OVERVIEW
11.4.11.2. PRODUCT PORTFOLIO
11.4.11.3. STRATEGIC INITIATIVES
11.4.11.4. SCOT ANALYSIS
11.4.12. ONCORE MEDICAL INC.
11.4.12.1. OVERVIEW
11.4.12.2. PRODUCT PORTFOLIO
11.4.12.3. STRATEGIC INITIATIVES
11.4.12.4. SCOT ANALYSIS
11.4.13. RECURSION PHARMACEUTICALS INC.
11.4.13.1. OVERVIEW
11.4.13.2. PRODUCT PORTFOLIO
11.4.13.3. STRATEGIC INITIATIVES
11.4.13.4. SCOT ANALYSIS
11.4.14. STRYKER CORPORATION
11.4.14.1. OVERVIEW
11.4.14.2. PRODUCT PORTFOLIO
11.4.14.3. STRATEGIC INITIATIVES
11.4.14.4. SCOT ANALYSIS
11.4.15. WELLTOK INC
11.4.15.1. OVERVIEW
11.4.15.2. PRODUCT PORTFOLIO
11.4.15.3. STRATEGIC INITIATIVES
11.4.15.4. SCOT ANALYSIS

TABLE LIST
TABLE 1: NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY COUNTRY, 2017-2025 (IN $ MILLION)
TABLE 2: REGULATORY FRAMEWORK OF AI IN HEALTHCARE MARKET
TABLE 3: NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY OFFERINGS, 2017-2025 (IN $ MILLION)
TABLE 4: NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY TECHNOLOGY, 2017-2025 (IN $ MILLION)
TABLE 5: NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY APPLICATION, 2017-2025 (IN $ MILLION)
TABLE 6: NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USERS, 2017-2025 (IN $ MILLION)
TABLE 7: OPPORTUNITY MATRIX FOR ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET
TABLE 8: NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY COUNTRY, 2017-2025 (IN $ MILLION)
TABLE 9: LIST OF PRODUCT LAUNCHES IN ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET
TABLE 10: LIST OF PARTNERSHIP & COLLABORATION IN ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET
TABLE 11: LIST OF MERGER & ACQUISITION IN ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET
TABLE 12: LIST OF INVESTMENTS IN ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET
TABLE 13: LIST OF EXPANSIONS IN ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET

FIGURE LIST
FIGURE 1: NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USERS, 2016 & 2025 (IN $ MILLION)
FIGURE 2: GROWTH OF ARTIFICIAL INTELLIGENCE IN HEALTHCARE
FIGURE 3: INDUSTRY COMPONENTS
FIGURE 4: NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, 2017-2025 (IN $ MILLION)
FIGURE 5: INCREASING INTERNET USERS NORTH AMERICA (% OF POPULATION)
FIGURE 6: NORTH AMERICA HEALTHCARE IOT DEVICES INSTALLATIONS
FIGURE 7: NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY OFFERINGS, 2016 & 2025 (IN $ MILLION)
FIGURE 8: NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY HARDWARE, 2017-2025 (IN $ MILLION)
FIGURE 9: NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY SOFTWARE, 2017-2025 (IN $ MILLION)
FIGURE 10: NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY SERVICES, 2017-2025 (IN $ MILLION)
FIGURE 11: NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY TECHNOLOGY, 2016 & 2025 (IN $ MILLION)
FIGURE 12: NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY CONTEXT AWARE PROCESSING, 2017-2025 (IN $ MILLION)
FIGURE 13: NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY DEEP LEARNING, 2017-2025 (IN $ MILLION)
FIGURE 14: NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY NATURAL LANGUAGE PROCESSING, 2017-2025 (IN $ MILLION)
FIGURE 15: NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY QUERYING METHOD, 2017-2025 (IN $ MILLION)
FIGURE 16: NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY APPLICATION, 2016 & 2025 (IN $ MILLION)
FIGURE 17: NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY DRUG DISCOVERY, 2017-2025 (IN $ MILLION)
FIGURE 18: NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY INPATIENT CARE & HOSPITAL MANAGEMENT, 2017-2025 (IN $ MILLION)
FIGURE 19: NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY LIFESTYLE MANAGEMENT & MONITORING, 2017-2025 (IN $ MILLION)
FIGURE 20: NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY MEDICAL IMAGING & DIAGNOSTICS, 2017-2025 (IN $ MILLION)
FIGURE 21: NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY PATIENT DATA & RISK ANALYSIS, 2017-2025 (IN $ MILLION)
FIGURE 22: NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY PRECISION MEDICINE, 2017-2025 (IN $ MILLION)
FIGURE 23: NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY RESEARCH, 2017-2025 (IN $ MILLION)
FIGURE 24: NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY VIRTUAL ASSISTANT, 2017-2025 (IN $ MILLION)
FIGURE 25: NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY WEARABLES, 2017-2025 (IN $ MILLION)
FIGURE 26: NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USERS, 2016 & 2025 (IN $ FIGURE)
FIGURE 27: NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY ACOS & MCOS, 2017-2025 (IN $ MILLION)
FIGURE 28: NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY PATIENTS, 2017-2025 (IN $ MILLION)
FIGURE 29: NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY PAYERS, 2017-2025 (IN $ MILLION)
FIGURE 30: NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2017-2025 (IN $ MILLION)
FIGURE 31: NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY PROVIDERS, 2017-2025 (IN $ MILLION)
FIGURE 32: PORTER’S FIVE FORCE MODEL OF ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET
FIGURE 33: KEY BUYING IMPACT ANALYSIS
FIGURE 34: INVESTMENT ANALYSIS OF ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET IN 2016, BY FASTEST GROWING REVENUE SEGMENTS
FIGURE 35: NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY REGION, 2016 & 2025 (IN %)
FIGURE 36: UNITED STATES ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, 2017-2025 (IN $ MILLION)
FIGURE 37: CANADA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, 2017-2025 (IN $ MILLION)
FIGURE 38: MARKET SHARE ANALYSIS OF TOP PLAYERS IN 2016 (%)